Open AccessMethamphetamine Associated Cardiomyopathy in Pregnancy: The Distinctions and the Implications
Author(s) -
Ashan T Hatharasinghe,
Hossein Akhondi
Publication year - 2021
Publication title -
hca healthcare journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 2690-3830
pISSN - 2689-0216
DOI - 10.36518/2689-0216.1140
Subject(s) - medicine , cardiomyopathy , peripartum cardiomyopathy , pregnancy , heart failure , ejection fraction , methamphetamine , preeclampsia , population , intensive care medicine , cardiology , environmental health , biology , genetics
Methamphetamine associated cardiomyopathy (MAC) and peripartum cardiomyopathy (PPCM) are both rare obstetric conditions. Literature regarding methamphetamine associated cardiomyopathy in the obstetric population is limited, and it can be difficult to make the distinction between the two given the similarities in clinical presentation. However similar, there are significant distinctions in the pathophysiology of these two that can help clinicians with the management process.